Recruiting
Who can join AIPeople with intestinal Behcet syndrome.
What is being studied AITests baricitinib versus adalimumab for treating refractory intestinal Behçet's syndrome over 24 weeks.
Study typeTreatment (drug) · Phase 2
CountriesChina
Behçet's Disease
Browse recruiting and upcoming clinical trials for Behçet's disease.
Patient-friendly, AI-assisted summaries based on official ClinicalTrials.gov ↗ records. Last updated: Oct 10, 2026
About this listHide
ClinicalTrials.gov is the complete and most up-to-date source. Trials may be missing, and trial information may have changed since our last check. Always verify important information in the official registry.
Recruiting
Who can join AIPeople with multiple refractory autoimmune diseases, including Systemic Lupus Erythematosus, Systemic Sclerosis, Sjögren syndrome, and others.
What is being studied AITests BCMA‑CD19 CAR‑T cell therapy for multiple refractory autoimmune diseases.
Study typeTreatment (drug) · Phase 2
CountriesChina
Recruiting
Who can join AIPeople with antiphospholipid syndrome, bullous pemphigoid, Behçet's syndrome, dermatomyositis, immune‑mediated necrotizing myopathy, or immune thrombocytopenia.
What is being studied AITests multiple doses of RAY121 (classical complement pathway inhibitor) for safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy.
Study typeTreatment (drug) · Phase 1
CountriesAustralia, Austria, Bulgaria +17
Recruiting
Who can join AIPeople with Behçet's disease, idiopathic inflammatory myopathies (myositis), or IgG4-related disease.
What is being studied AITests daily oral filgotinib for 26 weeks on disease activity, quality of life, and safety.
Study typeTreatment (drug) · Phase 2
CountriesNetherlands
Recruiting
Who can join AIAdults aged 18–75 with Behçet's disease who have active oral ulcers meeting the study's screening and randomization counts.
What is being studied AITests two doses of Hemay005 tablets versus placebo for effects on oral ulcers in Behçet's Disease.
Study typeTreatment (drug) · Phase 3
CountriesChina
Recruiting
Who can join AIChildren with Behçet's disease (oral ulcers, age 2 and older) or juvenile psoriatic arthritis (age 5 to <18) who completed Week 52 of an apremilast core study.
What is being studied AITests long-term safety of apremilast in children with oral ulcers from Behçet's or JPsA.
Study typeTreatment (drug) · Phase 3
CountriesGreece, Israel, Spain +1
Recruiting
Who can join AIChildren aged 2 to <18 years with Behçet's disease who have active oral ulcers.
What is being studied AICompares oral apremilast with placebo for treating oral ulcers in pediatric Behçet's disease.
Study typeTreatment (drug) · Phase 3
CountriesFrance, Greece, Israel +5
Not yet recruiting
Who can join AIPeople with Behçet's syndrome.
What is being studied AITests whether ACTH injections change oral and genital mucosal lesions in Behçet's syndrome.
Study typeTreatment (drug) · Phase 2
CountriesChina
Not yet recruiting
Who can join AIAdults (18–75) with Behçet's disease who have recurrent oral ulcers.
What is being studied AITests HSK44459 tablets versus placebo for oral and genital ulcers in Behçet's disease.
Study typeTreatment (drug) · Phase 2
CountriesNot posted yet
Not yet recruiting
Who can join AIAdults (18–100) with sight‑threatening, non‑infectious Behcet's uveitis (intermediate, posterior or panuveitis).
What is being studied AICompares adalimumab and tocilizumab for sight‑threatening Behcet's uveitis.
Study typeTreatment (drug) · Phase 2
CountriesNot posted yet
Enrolling by invitation
Who can join AIPeople with Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM), Immune‑mediated Necrotizing Myopathy (IMNM), or Immune Thrombocytopenia (ITP).
What is being studied AILong-term safety, RAY121 blood levels, and complement activity.
Study typeTreatment (drug) · Phase 1
CountriesAustralia, Austria, Bulgaria +16
Recruiting
Who can join AIPeople with Behçet disease (children and people) and healthy pediatric controls.
What is being studied AICollects blood to profile cytokines, circulating microRNA, DNA methylation and genetic variants.
Study typeOther
CountriesItaly, United Kingdom
Recruiting
Who can join AIAdults (18+) with an immune-mediated inflammatory disease such as lupus, multiple sclerosis, psoriatic arthritis, severe asthma, atopic dermatitis, angioedema, systemic sclerosis, or Behçet disease.
What is being studied AICollects clinical data, yearly disease measures, quality-of-life surveys, and blood samples for biomarker and genetic research.
Study typeOther
CountriesFrance
Recruiting
Who can join AIAdults with Takayasu arteritis, adults with Behçet's disease, or healthy adults without chronic inflammatory disease.
What is being studied AICompares respiratory and muscle strength, exercise capacity, body composition, and quality-of-life measures across groups.
Study typeObservational
CountriesTurkey
Recruiting
Ustekinumab in BEhçet's Syndrome STudy
NCT07244614
Who can join AIPeople with mucocutaneous Behçet's syndrome.
What is being studied AICollects routine-care data to describe biosimilar ustekinumab and compare with apremilast.
Study typeObservational
CountriesFrance
Recruiting
Who can join AIPeople with suspected or known inflammatory cardiovascular involvement from a range of conditions — for example myocarditis, pericarditis, sarcoidosis, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, Takayasu arteritis, and others.
What is being studied AICollects imaging and clinical data from CMR, cardiac PET, and echocardiography to detect heart involvement.
Study typeObservational
CountriesFrance
Recruiting
Who can join AIPeople with systemic autoimmune or autoinflammatory diseases (for example Behcet disease; ANCA-positive vasculitis; Takayasu or giant cell arteritis; Sjögren's; rheumatoid arthritis; celiac disease).
What is being studied AICollects clinical data, disease activity scores, and blood and stool samples for a biobank.
Study typeObservational
CountriesArmenia
Recruiting
Vasculitis Pregnancy Registry
NCT02593565
Who can join AIPregnant women with vasculitis, including Behçet's disease, granulomatosis with polyangiitis, Takayasu arteritis, polyarteritis nodosa, and others.
What is being studied AICollects online questionnaires about vasculitis severity, pregnancy experiences, and pregnancy outcomes.
Study typeObservational
CountriesUnited States
Not yet recruiting
Who can join AIPeople with Behçet's disease and healthy control participants.
What is being studied AIMeasures serum EBI-3 protein levels in people with Behçet's disease and healthy controls.
Study typeObservational
CountriesNot posted yet
Not yet recruiting
Asprosin in Behect Patients
NCT07803198
Who can join AIPeople with Behcet Disease and age- and sex-matched healthy volunteers.
What is being studied AIMeasures serum Asprosin and compares levels with disease activity in Behcet Disease
Study typeObservational
CountriesNot posted yet
Not yet recruiting
Who can join AIPeople with inflammatory cardiovascular diseases and autoimmune rheumatic diseases (e.g., myocarditis, pericarditis, lupus, rheumatoid arthritis).
What is being studied AICollect blood samples to build a biobank and perform immunophenotyping and proteomic analyses.
Study typeObservational
CountriesNot posted yet
Not yet recruiting
Who can join AIAdults (18+) with a confirmed diagnosis of Behçet's disease who meet ISG and rICBD diagnostic criteria.
What is being studied AICollects clinical, laboratory, and treatment data to describe Behçet's disease presentations and therapies.
Study typeObservational
CountriesNot posted yet
Not yet recruiting
Who can join AIAdults (18–75) with Behçet's disease or healthy adult controls being compared for cranial nerve function.
What is being studied AITests whether cranial nerves are affected in Behçet's disease versus healthy controls
Study typeObservational
CountriesTurkey
Not yet recruiting
Evaluation of Voice in Behcet's
NCT06836817
Who can join AIPeople with Behçet's disease and people without Behçet's disease (control participants).
What is being studied AIExamines vocal cord involvement using laryngoscopy and acoustic voice measurements.
Study typeObservational
CountriesNot posted yet
Recruiting
Who can join AIPeople with Behçet disease.
What is being studied AIMeasures femoral vein wall thickness and inflammatory markers in people with Behçet.
Study typeRegistry
CountriesEgypt
Recruiting
Who can join AIPeople with monogenic or polygenic autoinflammatory diseases, for example Behçet disease, Still disease, PFAPA, Schnitzler and VEXAS.
What is being studied AICollects clinical, genetic, treatment, laboratory, radiologic and socio-economic data in a long-term registry.
Study typeRegistry
CountriesAlgeria, Australia, Belgium +19
Recruiting
Who can join AIAdults with rheumatic autoimmune diseases (for example rheumatoid arthritis, lupus, scleroderma, ankylosing spondylitis) and healthy adult volunteers.
What is being studied AICollects clinical data and biospecimens (blood, saliva, urine, stool, tissue) for research.
Study typeRegistry
CountriesUnited States
Trials that may include Behçet's disease (7)
ClinicalTrials.gov returned these when we searched for this condition, but we could not confirm from the registry records that they are intended for people with it. Check each trial’s eligibility criteria, and ask the study team if you are unsure.
Recruiting
Who can join AIPeople with Behcet Disease who are obese and have subjective tinnitus.
What is being studied AIA 12-week low-calorie diet versus waitlist for tinnitus and quality-of-life in Behcet disease with obesity
Study typeTreatment (other)
CountriesEgypt
Recruiting
Who can join AIPeople with metabolic syndrome and Behcet disease.
What is being studied AITests a 12-week treadmill walking program's effect on metabolic and quality-of-life measures.
Study typeTreatment (other)
CountriesEgypt
Recruiting
Who can join AIPeople with Behcet disease who have had pulmonary endoarterectomy.
What is being studied AITests a 12-week inspiratory muscle training program's effects on lung function and patient measures.
Study typeTreatment (procedure/device)
CountriesEgypt
Recruiting
Who can join AIPeople with Behçet's syndrome who have a current or recurrent deep venous thrombosis (DVT).
What is being studied AICompares steroids plus rivaroxaban versus steroids alone for DVT in Behçet's syndrome
Study typeTreatment (drug) · Phase 3
CountriesFrance
Recruiting
Who can join AIPeople with vascular Behçet's syndrome or aneurysm.
What is being studied AITests tocilizumab or tofacitinib plus steroids versus cyclophosphamide plus steroids for vascular Behçet's.
Study typeTreatment (drug) · Phase 2
CountriesChina
Not yet recruiting
Who can join AIAdults aged 18–50 with Behçet's disease (diagnosed using International Study Group criteria) who had lower-extremity venous thrombosis confirmed within the past 14 days. The registry also requires either no previous vascular involvement or no previous immunosuppressive treatment for vascular involvement.
What is being studied AICompares immunosuppression alone versus immunosuppression plus rivaroxaban for Behçet-related leg clots.
Study typeTreatment (drug) · Phase 3
CountriesTurkey
Recruiting
Who can join AIPeople with anterior uveitis (many causes), people with posterior vitreous detachment (floaters), and healthy control volunteers.
What is being studied AIWhether OCT can count and classify inflammatory eye cells and signals and compare with clinical grading.
Study typeObservational
CountriesUnited States